BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28321691)

  • 1. Patient-Specific Resection Strategy of Glioblastoma Multiforme: Choice Based on a Preoperative Scoring Scale.
    Jiang H; Cui Y; Liu X; Ren X; Lin S
    Ann Surg Oncol; 2017 Jul; 24(7):2006-2014. PubMed ID: 28321691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.
    Adams H; Adams HH; Jackson C; Rincon-Torroella J; Jallo GI; Quiñones-Hinojosa A
    Childs Nerv Syst; 2016 Mar; 32(3):493-503. PubMed ID: 26767842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
    Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
    Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma.
    Neidert MC; Hostettler IC; Burkhardt JK; Mohme M; Held U; Kofmehl R; Eisele G; Woernle CM; Regli L; Bozinov O
    Neurosurg Rev; 2016 Jul; 39(3):401-9. PubMed ID: 26860420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
    Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
    World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Surgical Resection, Disability, and Survival in Patients with Glioblastoma.
    Ahmadipour Y; Kaur M; Pierscianek D; Gembruch O; Oppong MD; Mueller O; Jabbarli R; Glas M; Sure U; El Hindy N
    J Neurol Surg A Cent Eur Neurosurg; 2019 Jul; 80(4):262-268. PubMed ID: 30965373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
    Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
    World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.
    Shah AH; Mahavadi A; Di L; Sanjurjo A; Eichberg DG; Borowy V; Figueroa J; Luther E; de la Fuente MI; Semonche A; Ivan ME; Komotar RJ
    J Neurooncol; 2020 Jul; 148(3):501-508. PubMed ID: 32627128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resection.
    Schneider M; Potthoff AL; Keil VC; Güresir Á; Weller J; Borger V; Hamed M; Waha A; Vatter H; Güresir E; Herrlinger U; Schuss P
    J Neurooncol; 2019 Oct; 145(1):143-150. PubMed ID: 31485921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
    Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
    Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
    Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
    J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Examination of the Role of Supramaximal Resection of Temporal Lobe Glioblastoma Multiforme.
    Glenn CA; Baker CM; Conner AK; Burks JD; Bonney PA; Briggs RG; Smitherman AD; Battiste JD; Sughrue ME
    World Neurosurg; 2018 Jun; 114():e747-e755. PubMed ID: 29555603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of removed tumor volume and location on patient outcome in glioblastoma.
    Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
    J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.
    Kreth FW; Thon N; Simon M; Westphal M; Schackert G; Nikkhah G; Hentschel B; Reifenberger G; Pietsch T; Weller M; Tonn JC;
    Ann Oncol; 2013 Dec; 24(12):3117-23. PubMed ID: 24130262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.
    Kuhnt D; Becker A; Ganslandt O; Bauer M; Buchfelder M; Nimsky C
    Neuro Oncol; 2011 Dec; 13(12):1339-48. PubMed ID: 21914639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme.
    Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A
    Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.